SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK
32.56
06-May-25 09:39:46
15 minutes delayed
Stocks
+0.16
+0.51%
Today's range
31.87 - 32.75
ISIN
N/A
Source
NASDAQ
-
Supernus Enters Into $150 Million Credit Facility
14 Feb 2023 16:30:00 By Nasdaq GlobeNewswire
-
09 Feb 2023 18:15:05 By Nasdaq GlobeNewswire
-
Supernus to Present at the Piper Sandler 34th Annual Healthcare Conference
22 Nov 2022 17:00:00 By Nasdaq GlobeNewswire
-
Supernus to Present at Two November Healthcare Conferences
08 Nov 2022 17:30:00 By Nasdaq GlobeNewswire
-
Supernus Announces Third Quarter 2022 Financial Results
08 Nov 2022 16:05:02 By Nasdaq GlobeNewswire
-
25 Oct 2022 16:30:00 By Nasdaq GlobeNewswire
-
Supernus Provides Regulatory Update on SPN-830
10 Oct 2022 08:30:00 By Nasdaq GlobeNewswire
-
Supernus to Present at the 2022 Wells Fargo Healthcare Conference
31 Aug 2022 16:00:00 By Nasdaq GlobeNewswire
-
Supernus Announces Second Quarter 2022 Financial Results
04 Aug 2022 16:01:00 By Nasdaq GlobeNewswire
-
25 Jul 2022 17:00:00 By Nasdaq GlobeNewswire
-
Supernus to Participate in the Jefferies Healthcare Conference
02 Jun 2022 16:05:00 By Nasdaq GlobeNewswire
-
Supernus Announces First Quarter 2022 Financial Results
09 May 2022 16:05:01 By Nasdaq GlobeNewswire
-
02 May 2022 16:55:00 By Nasdaq GlobeNewswire
-
Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults
29 Apr 2022 20:00:38 By Nasdaq GlobeNewswire
-
Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results
13 Apr 2022 16:11:14 By Nasdaq GlobeNewswire
-
Supernus Provides Update on Filing of Annual Report and Reiterates Full Year 2022 Financial Guidance
04 Apr 2022 17:00:00 By Nasdaq GlobeNewswire
-
17 Mar 2022 08:30:00 By Nasdaq GlobeNewswire
-
Supernus to Participate in Annual Cowen Health Care Conference
02 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
Supernus Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results
28 Feb 2022 16:05:01 By Nasdaq GlobeNewswire
-
22 Feb 2022 16:30:00 By Nasdaq GlobeNewswire